321 related articles for article (PubMed ID: 6848428)
1. Chemical and physical properties of gall stones in South Australia: implications for dissolution treatment.
Whiting MJ; Bradley BM; Watts JM
Gut; 1983 Jan; 24(1):11-5. PubMed ID: 6848428
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting gall-stone dissolution rate during chenic acid therapy.
Maudgal DP; Kupfer RM; Northfield TC
Gut; 1983 Jan; 24(1):7-10. PubMed ID: 6848433
[TBL] [Abstract][Full Text] [Related]
3. Chemical composition of gallstones resistant to dissolution therapy with chenodeoxycholic acid.
Whiting MJ; Jarvinen V; Watts JM
Gut; 1980 Dec; 21(12):1077-81. PubMed ID: 7461466
[TBL] [Abstract][Full Text] [Related]
4. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
[TBL] [Abstract][Full Text] [Related]
5. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
Iser JH; Maton PN; Murphy GM; Dowling RH
Br Med J; 1978 Jun; 1(6126):1509-12. PubMed ID: 656777
[TBL] [Abstract][Full Text] [Related]
6. Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
Sahlin S; Danielsson A; Angelin B; Reihnér E; Henriksson R; Einarsson K
Gut; 1988 Nov; 29(11):1506-10. PubMed ID: 3209106
[TBL] [Abstract][Full Text] [Related]
7. Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid.
Hussaini SH; Pereira SP; Murphy GM; Kennedy C; Wass JA; Besser GM; Dowling RH
Gut; 1995 Jan; 36(1):126-32. PubMed ID: 7890216
[TBL] [Abstract][Full Text] [Related]
8. Gall stone dissolving agents.
Bouchier IA
Br Med J (Clin Res Ed); 1983 Mar; 286(6367):778-80. PubMed ID: 6402249
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones. Correlation of lucency or opaqueness with calcium and mineral.
Trotman BW; Petrella EJ; Soloway RD; Sanchez HM; Morris TA; Miller WT
Gastroenterology; 1975 Jun; 68(6):1563-6. PubMed ID: 1093922
[TBL] [Abstract][Full Text] [Related]
10. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
Ruppin DC; Murphy GM; Dowling RH
Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
[TBL] [Abstract][Full Text] [Related]
11. Duodenal bile examination in identifying potential non-responders to bile salt treatment and its comparison with gall bladder bile examination.
Agarwal DK; Choudhuri G; Saraswat VA; Negi TS; Kapoor VK; Saxena R
Gut; 1994 Jan; 35(1):112-6. PubMed ID: 8307430
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy.
Walters JR; Hood KA; Gleeson D; Ellul JP; Keightley A; Murphy GM; Dowling RH
Gut; 1992 Mar; 33(3):375-80. PubMed ID: 1568659
[TBL] [Abstract][Full Text] [Related]
13. Gall-stone dissolution treatment using cholelitholytic bile acids: experience with 24 patients.
van Erpecum KJ; van Berge Henegouwen GP; van der Werf SD
Neth J Med; 1989 Feb; 34(1-2):3-9. PubMed ID: 2644556
[TBL] [Abstract][Full Text] [Related]
14. [Selection of patients with gallstones for litholysis (author's transl)].
Wolpers C
Leber Magen Darm; 1976; 6(1):43-46. PubMed ID: 972572
[TBL] [Abstract][Full Text] [Related]
15. [In vivo dissolving of gall-stones: the effect of chenodeoxycholic acid. (author's transl)].
Fromm H; Eschler A; Töllner D; Canzler H; Schmidt FW
Dtsch Med Wochenschr; 1975 Aug; 100(32):1619-24. PubMed ID: 170051
[TBL] [Abstract][Full Text] [Related]
16. Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones.
Sahlin S; Ahlberg J; Einarsson K; Henriksson R; Danielsson A
Gut; 1990 Jan; 31(1):100-5. PubMed ID: 2318423
[TBL] [Abstract][Full Text] [Related]
17. Oral dissolution therapy for cholelithiasis: mix and match.
Phillips RS; Barkin JS
Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
[TBL] [Abstract][Full Text] [Related]
18. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
Nakano K; Chijiiwa K
Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation.
Ellis WR; Somerville KW; Whitten BH; Bell GD
Br Med J (Clin Res Ed); 1984 Jul; 289(6438):153-6. PubMed ID: 6430390
[TBL] [Abstract][Full Text] [Related]
20. Chemical and morphologic characteristics of cholesterol gallstones that failed to dissolve on chenodiol. The National Cooperative Gallstone Study.
Freilich HS; Malet PF; Schwartz JS; Soloway RD
Gastroenterology; 1986 Sep; 91(3):713-8. PubMed ID: 3732769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
